Healthcare company-building profile
LabCentral Ignite Golden Ticket
LabCentral (with pharma sponsors including Bayer, Lilly, Pfizer and Takeda)
IncubatorIncubatorNot publicly documentedActive
Source-based profile
Program at a Glance
- Program type
- Incubator
- Program category
- Incubator
- Organization
- LabCentral (with pharma sponsors including Bayer, Lilly, Pfizer and Takeda)
- Organization type
- Not publicly documented
- Location
- Cambridge, Massachusetts
- Company stage served
- Early stage
- Cohort or participation model
- Annual contest; winners receive a one-year LabCentral residency fellowship
- Investment or funding offered
- Yes
- Published investment terms
- $50,000 credit toward LabCentral lab space per ticket; no equity taken
- Equity or fee model
- No equity
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
- Founded
- 2021
Public description
About the program
LabCentral Ignite runs the umbrella Golden Ticket contest through which pharmaceutical sponsors fund one-year residencies for early-stage life science startups at LabCentral in Kendall Square. Each ticket carries a $50,000 credit toward lab space plus operational support, shared equipment, coaching, networking and pitch-event access. The program has run multiple annual cycles with a rotating slate of corporate sponsors.
What the program publicly emphasizes
Focus areas and features
Biotech and therapeuticsDiverse and underrepresented foundersWet-lab residency
- Category: Incubator
- Program structure: Annual contest; winners receive a one-year LabCentral residency fellowship
- Published terms: $50,000 credit toward LabCentral lab space per ticket; no equity taken
Publicly documented people and network
Program leadership and alumni
- Notable alumni named in public materials
- NeuroBionics
Sources
External source links open in a new tab.